Weiss RV, Clapauch R (2014) Infertilidade feminina de origem endócrina. Arq Bras Endocrinol Metabol 58(2):144–152. https://doi.org/10.1590/0004-2730000003021
Article
PubMed
Google Scholar
Unuane D, Tournaye H, Velkeniers B, Poppe K (2011) Endocrine disorders & female infertility. Best Pract Res Clin Endocrinol Metab 5(6):861–873
Article
Google Scholar
Scheffer JA, Scheffer B, Scheffer R, Florencio F, Grynberg M, Lozano DM (2018) Are age and anti-Müllerian hormone good predictors of ovarian reserve and response in women undergoing IVF? JBRA Assist Reprod 22(3):215–220. https://doi.org/10.5935/1518-0557.20180043
Article
PubMed
PubMed Central
Google Scholar
Nelson SM (2013) Biomarkers of ovarian response: current and future applications. Fertil Steril 99(4):963–969. https://doi.org/10.1016/j.fertnstert.2012.11.051
Article
CAS
PubMed
Google Scholar
Andersen AN, Goossens V, Gianaroli L, Felberbaum R, De Mouzon J, Nygren KG (2007) Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum Reprod 22(6):1513–1525
Article
Google Scholar
Farquhar C, Marjoribanks J (2018) Assisted reproductive technology: an overview of Cochrane Reviews. Cochrane Database of Systematic Reviews (8):CD010537. https://doi.org/10.1002/14651858.CD010537.pub5
Mochtar MH, Van der Veen F, Ziech M, van Wely M, Musters A (2007) Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database of Systematic Reviews (2):CD005070. https://doi.org/10.1002/14651858.CD005070.pub2
Wang Y, Kuang Y, Chen Q, Cai R (2018) Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial. Trials 19(1):1–6
Article
Google Scholar
Hendriks DJ, te Velde ER, Looman CW, Bancsi LF, Broekmans FJ (2008) Expected poor ovarian response in predicting cumulative pregnancy rates: a powerful tool. Reprod BioMed Online 17(5):727–736. https://doi.org/10.1016/S1472-6483(10)60323-9
Article
PubMed
Google Scholar
Bukman A, Heineman MJ (2001) Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod Update 7(6):581–590. https://doi.org/10.1093/humupd/7.6.581
Article
CAS
PubMed
Google Scholar
Van Disseldorp J, Eijkemans MJ, Klinkert ER, Te Velde ER, Fauser BC, Broekmans FJ (2007) Cumulative live birth rates following IVF in 41- to 43-year-old women presenting with favourable ovarian reserve characteristics. Reprod BioMed Online 14(4):455–463. https://doi.org/10.1016/S1472-6483(10)60893-0
Article
PubMed
Google Scholar
La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A (2010) Anti-Müllerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 16(2):113–130. https://doi.org/10.1093/humupd/dmp036
Article
CAS
PubMed
Google Scholar
Kelsey TW, Wright P, Nelson SM, Anderson RA, Wallace WH (2011) A validated model of serum anti-Müllerian hormone from conception to menopause. PLoS One 6(7):e22024. https://doi.org/10.1371/journal.pone.0022024
Article
CAS
PubMed
PubMed Central
Google Scholar
Tal R, Tal O, Seifer BJ, Seifer DB (2015) Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis. Fertil Steril 103(1):119–130. https://doi.org/10.1016/j.fertnstert.2014.09.041
Article
CAS
PubMed
Google Scholar
Arce JC, La Marca A, Klein BM, Andersen AN, Fleming R (2013) Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients. Fertil Steril 99(6):1644–1653. https://doi.org/10.1016/j.fertnstert.2012.12.048
Article
CAS
PubMed
Google Scholar
Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho HN, Yang YS, Lee MS (2008) Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Hum Reprod 23(1):160–167. https://doi.org/10.1093/humrep/dem254
Article
CAS
PubMed
Google Scholar
Meczekalski B, Czyzyk A, Kunicki M, Podfigurna-Stopa A, Plociennik L, Jakiel G, Maciejewska-Jeske M, Lukaszuk K (2016) Fertility in women of late reproductive age: the role of serum anti-Müllerian hormone (AMH) levels in its assessment. J Endocrinol Investig 39(11):1259–1265. https://doi.org/10.1007/s40618-016-0497-6
Article
CAS
Google Scholar
Lee RW, Khin LW, Hendricks MS, Tan HH, Nadarajah S, Tee NW, Loh SF, Tai BC, Chan JK (2020) Ovarian biomarkers predict controlled ovarian stimulation for in vitro fertilisation treatment in Singapore. Singap Med J 61(9):463–468. https://doi.org/10.11622/smedj.2020130
Article
CAS
Google Scholar
Yassin MM, Sharif FA, Laqqan MM (2013) Anti-Mullerian hormone as a predictor of ovarian reserve and ovarian response in IVF women from Gaza strip. Iran J Reprod Med 11(4):261
CAS
Google Scholar
Popovic-Todorovic B, Loft A, Bredkjæer HE, Bangsbøll S, Nielsen IK, Andersen AN (2003) A prospective randomized clinical trial comparing an individual dose of recombinant FSH based on predictive factors versus a ‘standard’ dose of 150 IU/day in ‘standard’ patients undergoing IVF/ICSI treatment. Hum Reprod 18(11):2275–2282. https://doi.org/10.1093/humrep/deg472
Article
CAS
PubMed
Google Scholar
Baker VL, Gracia C, Glassner MJ, Schnell VL, Doody K, Coddington CC, Shin SS, Marshall LA, Alper MM, Morales AJ, Pavone ME (2018) Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Fertil Steril 110(3):506–513 Rep
Article
CAS
Google Scholar
Bosch E, Labarta E, Zuzuarregui J, Iliodromiti S, Nelson SM (2018) Prediction of ovarian response with an automated AMH assay (Elecsys®) in GnRH antagonist cycles. Fertil Steril 110(4):e330. https://doi.org/10.1016/j.fertnstert.2018.07.926
Article
Google Scholar
Liu XH, Wu XH, Yang S (2019) Changes and correlations of anti-Müllerian hormone and stem-cell factors in different ovarian reserve patients during GnRH-antagonist protocol and the effects on controlled ovarian hyperstimulation outcomes. Arch Gynecol Obstet 300(6):1773–1783. https://doi.org/10.1007/s00404-019-05332-4
Article
CAS
PubMed
Google Scholar
Ron-El R, Raziel A, Strassburger D, Schachter M, Kasterstein E, Friedler S (2000) Outcome of assisted reproductive technology in women over the age of 41. Fertil Steril 74(3):471–475. https://doi.org/10.1016/S0015-0282(00)00697-X
Article
CAS
PubMed
Google Scholar
Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RM (2002) Early follicular serum Müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77(3):468–471. https://doi.org/10.1016/S0015-0282(01)03201-0
Article
PubMed
Google Scholar
Vural B, Cakiroglu Y, Vural F, Filiz S (2014) Hormonal and functional biomarkers in ovarian response. Arch Gynecol Obstet 289(6):1355–1361. https://doi.org/10.1007/s00404-013-3132-1
Article
CAS
PubMed
Google Scholar
Umarsingh S, Adam JK, Krishna SB (2020) The relationship between anti-Müllerian hormone (AMH) levels and pregnancy outcomes in patients undergoing assisted reproductive techniques (ART). PeerJ 8:e10390 ADD
Article
Google Scholar
Fanchin R, Schonäuer LM, Righini C, Guibourdenche J, Frydman R, Taieb J (2003) Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3. Hum Reprod 18(2):323–327. https://doi.org/10.1093/humrep/deg042
Article
CAS
PubMed
Google Scholar
Huang J, Lin J, Gao H, Wang Y, Zhu X, Lu X, Wang B, Fan X, Cai R, Kuang Y (2019) Anti-Müllerian hormone for the prediction of ovarian response in progestin-primed ovarian stimulation protocol for IVF. Front Endocrinol 10:325 ADD
Article
Google Scholar
Saleh H, Moiety F, Agameya AF, Elkassar Y, El Sharakwy RM, Zeidan D, Elmeligy H (2020) Comparison between antral follicle count and anti-Müllerian hormonal level in the prediction of ovarian response and pregnancy outcome in intracytoplasmic sperm injection patients: implications in personalizing ovarian stimulation. Clin Exp Obstet Gynecol 47(2):166–173 ADD
Article
Google Scholar
Neves AR, Blockeel C, Griesinger G, Garcia-Velasco JA, La Marca A, Rodriguez I, Drakopoulos P, Alvarez M, Tournaye H, Polyzos NP (2020) The performance of the Elecsys® anti-Müllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa. Reprod BioMed Online 41(1):29–36 ADD
Article
CAS
Google Scholar
Zheng H, Chen S, Du H, Ling J, Wu Y, Liu H, Liu J (2017) Ovarian response prediction in controlled ovarian stimulation for IVF using anti-Müllerian hormone in Chinese women: a retrospective cohort study. Medicine 96(13):e6495
Article
Google Scholar
Broer SL, Dólleman M, Van Disseldorp J, Broeze KA, Opmeer BC, Bossuyt PM, Eijkemans MJ, Mol BW, Broekmans FJ, Broer SL, Dólleman M (2013) Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertil Steril 100(2):420–429. https://doi.org/10.1016/j.fertnstert.2013.04.024
Article
PubMed
Google Scholar
La Marca A, Sunkara SK (2014) Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice. Hum Reprod Update 20(1):124–140. https://doi.org/10.1093/humupd/dmt037
Article
CAS
PubMed
Google Scholar
Iliodromiti S, Anderson RA, Nelson SM (2015) Technical and performance characteristics of anti-Müllerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update 21(6):698–710. https://doi.org/10.1093/humupd/dmu062
Article
CAS
PubMed
Google Scholar
Asada Y, Tsuiki M, Sonohara M, Fukunaga N, Hattori Y, Inoue D, Ito R, Hashiba Y (2019) Performance of anti-Müllerian hormone (AMH) levels measured by Beckman Coulter Access AMH assay to predict oocyte yield following controlled ovarian stimulation for in vitro fertilization. Reprod Med Biol 18(3):273–277. https://doi.org/10.1002/rmb2.12271
Article
CAS
PubMed
PubMed Central
Google Scholar
Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C (2008) Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 90(3):737–743. https://doi.org/10.1016/j.fertnstert.2007.07.1293
Article
CAS
PubMed
Google Scholar
Cui Y, Shi Y, Cui L, Han T, Gao X, Chen ZJ (2014) Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome. Fertil Steril 102(1):230–236. https://doi.org/10.1016/j.fertnstert.2014.03.032
Article
CAS
PubMed
Google Scholar
Freeman EW, Sammel MD, Lin H, Gracia CR (2012) Anti-Mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol 97(5):1673–1680. https://doi.org/10.1210/jc.2011-3032
Article
CAS
Google Scholar
Steiner AZ, Pritchard D, Stanczyk FZ, Kesner JS, Meadows JW, Herring AH, Baird DD (2017) Association between biomarkers of ovarian reserve and infertility among older women of reproductive age. JAMA 318(14):1367–1376
Article
CAS
Google Scholar
Lukaszuk K, Liss J, Kunicki M, Jakiel G, Wasniewski T, Woclawek-Potocka I, Pastuszek E (2014) Anti-Müllerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology. Reprod Biol 14(3):176–181. https://doi.org/10.1016/j.repbio.2014.03.004
Article
PubMed
Google Scholar
Moro F, Tropea A, Scarinci E, Leoncini E, Boccia S, Federico A, Alesiani O, Lanzone A, Apa R (2016) Anti-Müllerian hormone concentrations and antral follicle counts for the prediction of pregnancy outcomes after intrauterine insemination. Int J Gynecol Obstet 133(1):64–68. https://doi.org/10.1016/j.ijgo.2015.08.021
Article
CAS
Google Scholar
Yao L, Zhang W, Li H, Lin W (2015) The role of serum AMH and FF AMH in predicting pregnancy outcome in the fresh cycle of IVF/ICSI: a meta-analysis. Int J Clin Exp Med 8(2):1755–1767
PubMed
PubMed Central
Google Scholar
Lekamge DN, Barry M, Kolo M, Lane M, Gilchrist RB, Tremellen KP (2007) Anti-Müllerian hormone as a predictor of IVF outcome. Reprod BioMed Online 14(5):602–610. https://doi.org/10.1016/S1472-6483(10)61053-X
Article
CAS
PubMed
Google Scholar